Literature DB >> 26475591

Muscle metaboreflex activation during dynamic exercise vasoconstricts ischemic active skeletal muscle.

Jasdeep Kaur1, Tiago M Machado1, Alberto Alvarez1, Abhinav C Krishnan1, Hanna W Hanna1, Yasir H Altamimi1, Danielle Senador1, Marty D Spranger1, Donal S O'Leary2.   

Abstract

Metabolite accumulation due to ischemia of active skeletal muscle stimulates group III/IV chemosensitive afferents eliciting reflex increases in arterial blood pressure and sympathetic activity, termed the muscle metaboreflex. We and others have previously demonstrated sympathetically mediated vasoconstriction of coronary, renal, and forelimb vasculatures with muscle metaboreflex activation (MMA). Whether MMA elicits vasoconstriction of the ischemic muscle from which it originates is unknown. We hypothesized that the vasodilation in active skeletal muscle with imposed ischemia becomes progressively restrained by the increasing sympathetic vasoconstriction during MMA. We activated the metaboreflex during mild dynamic exercise in chronically instrumented canines via graded reductions in hindlimb blood flow (HLBF) before and after α1-adrenergic blockade [prazosin (50 μg/kg)], β-adrenergic blockade [propranolol (2 mg/kg)], and α1 + β-blockade. Hindlimb resistance was calculated as femoral arterial pressure/HLBF. During mild exercise, HLBF must be reduced below a threshold level before the reflex is activated. With initial reductions in HLBF, vasodilation occurred with the imposed ischemia. Once the muscle metaboreflex was elicited, hindlimb resistance increased. This increase in hindlimb resistance was abolished by α1-adrenergic blockade and exacerbated after β-adrenergic blockade. We conclude that metaboreflex activation during submaximal dynamic exercise causes sympathetically mediated α-adrenergic vasoconstriction in ischemic skeletal muscle. This limits the ability of the reflex to improve blood flow to the muscle.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  exercise pressor reflex; ischemic skeletal muscle; metabolic vasodilation; muscle blood flow; sympathetically mediated vasoconstriction; α1- and β-blockade; β2-mediated vasodilation

Mesh:

Substances:

Year:  2015        PMID: 26475591      PMCID: PMC4698425          DOI: 10.1152/ajpheart.00679.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Alteration of humoral and peripheral vascular responses during graded exercise in heart failure.

Authors:  R L Hammond; R A Augustyniak; N F Rossi; K Lapanowski; J C Dunbar; D S O'Leary
Journal:  J Appl Physiol (1985)       Date:  2001-01

2.  Muscle metaboreflex control of ventricular contractility during dynamic exercise.

Authors:  Javier A Sala-Mercado; Robert L Hammond; Jong-Kyung Kim; Noreen F Rossi; Larry W Stephenson; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-23       Impact factor: 4.733

3.  Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress.

Authors:  G D Thomas; W Zhang; R G Victor
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

4.  Regional vascular resistance vs. conductance: which index for baroreflex responses?

Authors:  D S O'Leary
Journal:  Am J Physiol       Date:  1991-02

5.  Muscle chemoreflex-induced increases in right atrial pressure.

Authors:  D D Sheriff; R A Augustyniak; D S O'Leary
Journal:  Am J Physiol       Date:  1998-09

6.  Cardiovascular responses to graded reductions in hindlimb perfusion in exercising dogs.

Authors:  C R Wyss; J L Ardell; A M Scher; L B Rowell
Journal:  Am J Physiol       Date:  1983-09

7.  Muscle chemoreflex causes renal vascular constriction.

Authors:  S W Mittelstadt; L B Bell; K P O'Hagan; J E Sulentic; P S Clifford
Journal:  Am J Physiol       Date:  1996-03

8.  Functional sympatholysis is impaired in hypertensive humans.

Authors:  Wanpen Vongpatanasin; Zhongyun Wang; Debbie Arbique; Gary Arbique; Beverley Adams-Huet; Jere H Mitchell; Ronald G Victor; Gail D Thomas
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

9.  Muscle metaboreflex activation during dynamic exercise evokes epinephrine release resulting in β2-mediated vasodilation.

Authors:  Jasdeep Kaur; Marty D Spranger; Robert L Hammond; Abhinav C Krishnan; Alberto Alvarez; Robert A Augustyniak; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-24       Impact factor: 4.733

10.  Glycogen depletion-induced lactate reductions attenuate reflex responses in exercising humans.

Authors:  L I Sinoway; K J Wroblewski; S A Prophet; S M Ettinger; K S Gray; S K Whisler; G Miller; R L Moore
Journal:  Am J Physiol       Date:  1992-11
View more
  13 in total

1.  Central cardiovascular hemodynamic response to unilateral handgrip exercise with blood flow restriction.

Authors:  Daniel P Credeur; Raymond Jones; Daphney Stanford; Lee Stoner; Stephanie McCoy; Matthew Jessee
Journal:  Eur J Appl Physiol       Date:  2019-08-16       Impact factor: 3.078

2.  Altered arterial baroreflex-muscle metaboreflex interaction in heart failure.

Authors:  Jasdeep Kaur; Abhinav C Krishnan; Danielle Senador; Alberto Alvarez; Hanna W Hanna; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-03       Impact factor: 4.733

Review 3.  Clinical safety of blood flow-restricted training? A comprehensive review of altered muscle metaboreflex in cardiovascular disease during ischemic exercise.

Authors:  Michelle Cristina-Oliveira; Kamila Meireles; Marty D Spranger; Donal S O'Leary; Hamilton Roschel; Tiago Peçanha
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-08       Impact factor: 4.733

4.  Interaction between the muscle metaboreflex and the arterial baroreflex in control of arterial pressure and skeletal muscle blood flow.

Authors:  Jasdeep Kaur; Alberto Alvarez; Hanna W Hanna; Abhinav C Krishnan; Danielle Senador; Tiago M Machado; Yasir H Altamimi; Abe T Lovelace; Maryetta D Dombrowski; Marty D Spranger; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-09       Impact factor: 4.733

5.  Exaggerated coronary vasoconstriction limits muscle metaboreflex-induced increases in ventricular performance in hypertension.

Authors:  Marty D Spranger; Jasdeep Kaur; Javier A Sala-Mercado; Abhinav C Krishnan; Rania Abu-Hamdah; Alberto Alvarez; Tiago M Machado; Robert A Augustyniak; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-21       Impact factor: 4.733

6.  Muscle metaboreflex-induced vasoconstriction in the ischemic active muscle is exaggerated in heart failure.

Authors:  Jasdeep Kaur; Danielle Senador; Abhinav C Krishnan; Hanna W Hanna; Alberto Alvarez; Tiago M Machado; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-09-22       Impact factor: 4.733

7.  Exaggerated cardiovascular responses to treadmill running in rats with peripheral arterial insufficiency.

Authors:  J Matthew Kuczmarski; Kellee Unrath; Gail D Thomas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-06       Impact factor: 4.733

8.  The magnitude of the exercise pressor reflex is influenced by the active skeletal muscle mass in the decerebrate rat.

Authors:  Juan A Estrada; Guillaume P Ducrocq; Marc P Kaufman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-30       Impact factor: 3.619

9.  Muscle metaboreflex-induced increases in effective arterial elastance: effect of heart failure.

Authors:  Joseph Mannozzi; Jasdeep Kaur; Marty D Spranger; Mohamed-Hussein Al-Hassan; Beruk Lessanework; Alberto Alvarez; Charles S Chung; Donal S O'Leary
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-29       Impact factor: 3.619

10.  Ventricular contraction and relaxation rates during muscle metaboreflex activation in heart failure: are they coupled?

Authors:  Joseph Mannozzi; Louis Massoud; Jasdeep Kaur; Matthew Coutsos; Donal S O'Leary
Journal:  Exp Physiol       Date:  2020-12-09       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.